Michael Jaff
Directeur/Bestuurslid bij HEARTBEAM, INC.
Vermogen: 82 444 $ op 30-04-2024
Profiel
Michael R.
Jaff is the founder of Embolitech LLC, a company founded in 2016, where he holds the title of Chief Strategic Officer.
He is currently the Director at Access Vascular, Inc. and an Independent Director at HeartBeam, Inc., both of which are his current positions.
In the past, he worked as the Medical Director- Fireman Vascular Center at The General Hospital Corp.
In terms of education, Dr. Jaff completed his undergraduate degree at Dickinson College, obtained a doctorate from Kirksville College of Osteopathic Medicine, Inc., and also attended Harvard Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HEARTBEAM, INC.
0.16% | 24-07-2023 | 41 935 ( 0.16% ) | 82 444 $ | 30-04-2024 |
Actieve functies van Michael Jaff
| Bedrijven | Functie | Begin |
|---|---|---|
| HEARTBEAM, INC. | Directeur/Bestuurslid | 24-07-2023 |
Embolitech LLC
 Embolitech LLC Miscellaneous Commercial ServicesCommercial Services Embolitech LLC provides thrombomatrix technology. The firm’s initial research areas focus on the removal of organized thrombi and emboli. It’s Thrombomatrix technology will redefine treatment of peripheral vascular emboli and thrombi. The company was founded by Gary Ansel and Michael R. Jaff in 2016 and is headquartered in Austin, TX. | Oprichter | 01-01-2016 |
Access Vascular, Inc.
 Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Michael Jaff
| Bedrijven | Functie | Einde |
|---|---|---|
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Opleiding van Michael Jaff
| Dickinson College | Undergraduate Degree |
| Kirksville College of Osteopathic Medicine, Inc. | Doctorate Degree |
| Harvard Business School | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HEARTBEAM, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Access Vascular, Inc.
Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA. | Health Technology |
Embolitech LLC
Embolitech LLC Miscellaneous Commercial ServicesCommercial Services Embolitech LLC provides thrombomatrix technology. The firm’s initial research areas focus on the removal of organized thrombi and emboli. It’s Thrombomatrix technology will redefine treatment of peripheral vascular emboli and thrombi. The company was founded by Gary Ansel and Michael R. Jaff in 2016 and is headquartered in Austin, TX. | Commercial Services |
